Newton's Tree Raises £3.3M to Build the Procurement Layer for AI Healthcare Technology
May 14, 2024
Newton's Tree, a UK health technology company, has raised £3.3 million from Octopus Ventures, Calm/Storm Ventures, and other investors to build a platform that sits between healthcare AI developers and the health systems trying to adopt them. The company addresses what has become one of the most consequential bottlenecks in NHS modernisation: the absence of a trusted, structured way for NHS trusts and integrated care boards to discover, evaluate, procure, and monitor clinical AI products at scale.
The healthcare AI market has produced a growing catalogue of diagnostic tools, clinical decision support systems, workflow automation products, and patient monitoring platforms. Many of these have demonstrated meaningful clinical benefit in trial settings. Yet adoption within the NHS has been halting and inconsistent, driven in part by a procurement environment that is not structured for software-as-a-medical-device: fragmented evaluation processes, limited shared learning between trusts, limited post-deployment monitoring infrastructure, and an understandable institutional caution about deploying AI in clinical settings without robust evidence of real-world performance.
Newton's Tree's platform is designed to address these friction points systematically. The company provides NHS trusts with a curated marketplace of AI-powered clinical technologies, alongside the evaluation frameworks, evidence summaries, and procurement tooling needed to make confident purchasing decisions. Crucially, the platform extends beyond procurement into ongoing monitoring — enabling health systems to track the real-world performance of deployed AI tools, detect performance drift, and generate the kind of post-market surveillance data that regulators, commissioners, and clinicians need to maintain confidence in clinical AI over time. This lifecycle approach reflects the specific regulatory and governance requirements that distinguish clinical AI from general software procurement.
Octopus Ventures is one of the UK's most active early-stage investors in health technology, with a portfolio that spans digital therapeutics, medtech, and health infrastructure. Calm/Storm Ventures focuses on early-stage companies solving structural problems in healthcare. The combined investor base gives Newton's Tree both capital and a network of institutional relationships across the UK health innovation ecosystem. The funding will be used to develop the platform's core capabilities, build out the clinical AI catalogue, and deepen relationships with NHS trust partners.
Sources
Thank you to our Patrons & Partners:
